HOME >> MEDICINE >> NEWS
Wiley announces partnership with NASPGHAN and AASLD

Hoboken, N.J., September 6, 2006 -- Global publisher John Wiley & Sons, Inc., today announced a new agreement with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the American Association for the Study of Liver Diseases (AASLD) whereby Wiley will provide complimentary subscriptions of the journal Hepatology to all NASPGHAN fellows. Hepatology is an official journal of AASLD and is published on behalf of the Association by Wiley.

Hepatology is the premier worldwide journal publishing original, peer-reviewed articles concerning all aspects of liver structure, function, and disease.

"As chair of the AASLD Publications Committee, I am pleased that our publisher, John Wiley & Sons, Inc. is providing Hepatology without charge to trainees in Pediatric Gastroenterology/Hepatology," said William Balistreri, M.D. "Hepatology is the premier journal in the field and access to the important basic and translational research published in its pages will stimulate young investigators and we hope lead to the improved care of children with hepatobiliary disease."

"NASPGHAN welcomes this partnership with AASLD and Wiley and appreciates the generous support extended to the training and educating of our next generation of pediatric gastroenterologists," said Philip M. Sherman, M.D., President of NASPGHAN.


'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
6-Sep-2006


Page: 1

Related medicine news :

1. The Society of Hospital Medicine and Wiley to launch InfoPOEMs for hospitalists
2. Wiley acquires HEED, the worlds leading Health Economic Evaluations Database
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Wiley expands partnership with Skyscape
5. Crohns & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases
6. Wiley wins two 2005 PSP awards and three honorable mentions
7. Wiley acquires InfoPOEM, Inc.
8. New book on independent living through smart technologies available from Wiley
9. Wiley to publish UICC TNM Atlas in July 2005
10. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
11. AstraZeneca announces SYMBICORT is now available in the US

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... ... management in hospitals, today announced it has completed a round of funding to ... LLC and its partners. Black Granite Capital is a growth equity firm focused ...
(Date:4/26/2017)... ... ... Journal of Oral Implantology – Tooth loss is not simply an ... complications with speech, eating, and overcompensation of mouth due to the deficiency. To combat ... number of tooth replacements increase, it is imperative to design an implant that will ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet ... adoption of e-prescribing as measured in Part D Medicare data. The dataset, called ... pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") data ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology:
Cached News: